Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1894 1
1940 1
1945 1
1946 3
1947 6
1948 6
1949 3
1950 8
1951 5
1952 5
1953 13
1954 9
1955 17
1956 32
1957 24
1958 20
1959 4
1960 5
1961 9
1962 7
1963 10
1964 16
1965 8
1966 19
1967 21
1968 32
1969 21
1970 27
1971 16
1972 11
1973 12
1974 21
1975 19
1976 13
1977 21
1978 21
1979 36
1980 34
1981 24
1982 35
1983 34
1984 29
1985 40
1986 44
1987 49
1988 27
1989 38
1990 53
1991 39
1992 50
1993 62
1994 60
1995 63
1996 79
1997 58
1998 52
1999 68
2000 89
2001 72
2002 87
2003 94
2004 114
2005 99
2006 99
2007 105
2008 117
2009 141
2010 183
2011 186
2012 201
2013 209
2014 220
2015 243
2016 227
2017 250
2018 285
2019 314
2020 363
2021 379
2022 378
2023 320
2024 138

Text availability

Article attribute

Article type

Publication date

Search Results

5,727 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Komandan
Page 1
A method of high-throughput functional evaluation of EGFR gene variants of unknown significance in cancer.
Kohsaka S, Nagano M, Ueno T, Suehara Y, Hayashi T, Shimada N, Takahashi K, Suzuki K, Takamochi K, Takahashi F, Mano H. Kohsaka S, et al. Sci Transl Med. 2017 Nov 15;9(416):eaan6566. doi: 10.1126/scitranslmed.aan6566. Sci Transl Med. 2017. PMID: 29141884
Numerous variants of unknown significance (VUS) have been identified through large-scale cancer genome projects, although their functional relevance remains uninvestigated. We developed a mixed-all-nominated-mutants-in-one (MANO) method to evaluate the transforming potenti …
Numerous variants of unknown significance (VUS) have been identified through large-scale cancer genome projects, although their functional r …
Editorial.
Mano JF. Mano JF. Mater Today Bio. 2019 Jun 11;1:100012. doi: 10.1016/j.mtbio.2019.100012. eCollection 2019 Jan. Mater Today Bio. 2019. PMID: 32159141 Free PMC article. No abstract available.
HCM.
Mano T. Mano T. Int Heart J. 2018;59(2):243-244. doi: 10.1536/ihj.18-103. Int Heart J. 2018. PMID: 29607979 Free article. No abstract available.
Editorial Comment.
Mano R. Mano R. J Urol. 2020 Oct;204(4):713. doi: 10.1097/JU.0000000000001027.02. Epub 2020 Jul 27. J Urol. 2020. PMID: 32716276 No abstract available.
High-Throughput Functional Evaluation of Variants of Unknown Significance in ERBB2.
Nagano M, Kohsaka S, Ueno T, Kojima S, Saka K, Iwase H, Kawazu M, Mano H. Nagano M, et al. Clin Cancer Res. 2018 Oct 15;24(20):5112-5122. doi: 10.1158/1078-0432.CCR-18-0991. Epub 2018 Jul 2. Clin Cancer Res. 2018. PMID: 29967253
Herein, we comprehensively assessed the functional significance of the ERBB2 mutations in a high-throughput manner.Experimental Design: We evaluated the transforming activities and drug sensitivities of 55 nonsynonymous ERBB2 mutations using the mixed-all-nominated-in-one (MAN …
Herein, we comprehensively assessed the functional significance of the ERBB2 mutations in a high-throughput manner.Experimental Design: We e …
Comprehensive functional evaluation of variants of fibroblast growth factor receptor genes in cancer.
Nakamura IT, Kohsaka S, Ikegami M, Ikeuchi H, Ueno T, Li K, Beyett TS, Koyama T, Shimizu T, Yamamoto N, Takahashi F, Takahashi K, Eck MJ, Mano H. Nakamura IT, et al. NPJ Precis Oncol. 2021 Jul 16;5(1):66. doi: 10.1038/s41698-021-00204-0. NPJ Precis Oncol. 2021. PMID: 34272467 Free PMC article.
Herein, we evaluated the transforming activity and sensitivity of 160 nonsynonymous FGFR mutations and ten fusion genes to seven FGFR tyrosine kinase inhibitors (TKI) using the mixed-all-nominated-in-one (MANO) method, a high-throughput functional assay. The oncogenicity o …
Herein, we evaluated the transforming activity and sensitivity of 160 nonsynonymous FGFR mutations and ten fusion genes to seven FGFR tyrosi …
Dexmedetomidine for dyspnoea.
Mano A, Murata T, Date K, Kawata M, Sato M, Yamashita N, Iino K, Kyo S, Saito E. Mano A, et al. BMJ Support Palliat Care. 2023 Oct;13(e1):e84-e85. doi: 10.1136/bmjspcare-2020-002334. Epub 2020 Jun 11. BMJ Support Palliat Care. 2023. PMID: 32527791
Nanomaterials for Biomedical Applications.
Oliveira MB, Li F, Choi J, Mano JF. Oliveira MB, et al. Biotechnol J. 2020 Dec;15(12):e2000574. doi: 10.1002/biot.202000574. Biotechnol J. 2020. PMID: 33283977 No abstract available.
Biomimetic Interfaces in Biomedical Devices.
Mano JF, Choi IS, Khademhosseini A. Mano JF, et al. Adv Healthc Mater. 2017 Aug;6(15). doi: 10.1002/adhm.201700761. Adv Healthc Mater. 2017. PMID: 28792682 No abstract available.
Cancer genomic medicine in Japan.
Mano H. Mano H. Proc Jpn Acad Ser B Phys Biol Sci. 2020;96(7):316-321. doi: 10.2183/pjab.96.023. Proc Jpn Acad Ser B Phys Biol Sci. 2020. PMID: 32788553 Free PMC article. Review.
5,727 results